PMID- 21754917 OWN - NLM STAT- MEDLINE DCOM- 20111103 LR - 20211020 IS - 1687-5303 (Electronic) IS - 1687-5214 (Print) IS - 1687-5214 (Linking) VI - 2011 DP - 2011 TI - Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathy. PG - 212571 LID - 10.1155/2011/212571 [doi] LID - 212571 AB - Insulin signaling depends on tyrosine phosphorylation of insulin receptor substrates (IRSs) to mediate downstream effects; however, elevated serine phosphorylation of IRS impairs insulin signaling. Here, we investigated IRS protein expression patterns in dorsal root ganglia (DRG) of mice and whether their signaling was affected by diabetes. Both IRS1 and IRS2 are expressed in DRG; however, IRS2 appears to be the prevalent isoform and is expressed by many DRG neuronal subtypes. Phosphorylation of Ser(731)IRS2 was significantly elevated in DRG neurons from type 1 and type 2 diabetic mice. Additionally, Akt activation and neurite outgrowth in response to insulin were significantly decreased in DRG cultures from diabetic ob/ob mice. These results suggest that DRG neurons express IRS proteins that are altered by diabetes similar to other peripheral tissues, and insulin signaling downstream of the insulin receptor may be impaired in sensory neurons and contribute to the pathogenesis of diabetic neuropathy. FAU - Grote, C W AU - Grote CW AD - Department of Anatomy and Cell Biology, The University of Kansas Medical Center, Kansas City, KS 66160, USA. FAU - Morris, J K AU - Morris JK FAU - Ryals, J M AU - Ryals JM FAU - Geiger, P C AU - Geiger PC FAU - Wright, D E AU - Wright DE LA - eng GR - P20 RR016475/RR/NCRR NIH HHS/United States GR - P20 GM103418/GM/NIGMS NIH HHS/United States GR - P30 HD 002528/HD/NICHD NIH HHS/United States GR - R01 AG031575/AG/NIA NIH HHS/United States GR - P30 HD002528/HD/NICHD NIH HHS/United States GR - R01 NS043314/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110615 PL - United States TA - Exp Diabetes Res JT - Experimental diabetes research JID - 101274844 RN - 0 (Insulin) RN - 0 (Insulin Receptor Substrate Proteins) RN - 0 (Irs2 protein, mouse) RN - 0 (Leptin) RN - 5W494URQ81 (Streptozocin) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) SB - IM MH - Animals MH - Cells, Cultured MH - Diabetes Mellitus, Experimental/chemically induced/*complications MH - Diabetic Neuropathies/*metabolism/*physiopathology MH - Disease Models, Animal MH - Ganglia, Spinal/metabolism MH - Insulin/metabolism/pharmacology MH - Insulin Receptor Substrate Proteins/*metabolism MH - Insulin Resistance/genetics/*physiology MH - Leptin/genetics/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Neurites/drug effects MH - Neurons/*metabolism MH - Obesity/genetics/metabolism MH - Phosphorylation MH - Proto-Oncogene Proteins c-akt/metabolism MH - Signal Transduction/*physiology MH - Streptozocin/adverse effects PMC - PMC3132877 EDAT- 2011/07/15 06:00 MHDA- 2011/11/04 06:00 PMCR- 2011/06/15 CRDT- 2011/07/15 06:00 PHST- 2010/12/31 00:00 [received] PHST- 2011/03/22 00:00 [revised] PHST- 2011/04/15 00:00 [accepted] PHST- 2011/07/15 06:00 [entrez] PHST- 2011/07/15 06:00 [pubmed] PHST- 2011/11/04 06:00 [medline] PHST- 2011/06/15 00:00 [pmc-release] AID - 10.1155/2011/212571 [doi] PST - ppublish SO - Exp Diabetes Res. 2011;2011:212571. doi: 10.1155/2011/212571. Epub 2011 Jun 15.